Clinical Trials · NCT06939088
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Anders Fink-Jensen, MD, DMSci
- Enrollment
- 108
- Start date
- May 2025
- Locations
- 2 sites, Denmark
- Primary endpoint
- Change in heavy drinking days